HOOK (OTC)
HOOKIPA PHARMA INC
$1.150000
+0.010000 (+0.88%)
Prev close: $1.140000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Jörn Aldag
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $114.31M
- Employees
- 151
- P/E (TTM)
- -9.66
- P/B (TTM)
- 0.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2025 (Q1)
|
$-1.23 | $-1.06 | -0.1692 | -15.95% |
|
Dec 2024 (Q4)
|
$-1.99 | $-0.58 | -1.4069 | -241.28% |
|
Sep 2024 (Q3)
|
$-1.10 | $-1.30 | +0.2036 | +15.62% |
|
Jun 2024 (Q2)
|
$-1.52 | $-1.28 | -0.2424 | -18.97% |
Financial Statements
| Revenues | $9.35M |
| Benefits Costs and Expenses | $82.77M |
| Costs And Expenses | $89.79M |
| Nonoperating Income/Loss | $7.02M |
| Operating Expenses | $89.79M |
| Research and Development | $61.20M |
| Other Operating Expenses | $28.59M |
| Operating Income/Loss | -$80.44M |
| Income/Loss From Continuing Operations After Tax | -$73.31M |
| Income/Loss From Continuing Operations Before Tax | -$73.42M |
| Income Tax Expense/Benefit | -$106.00K |
| Net Income/Loss | -$73.31M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$73.31M |
| Net Income/Loss Available To Common Stockholders, Basic | -$73.31M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$5.84 |
| Diluted Earnings Per Share | -$5.84 |
| Basic Average Shares | 37,622,345 |
| Diluted Average Shares | 37,622,345 |
| Assets | $61.26M |
| Current Assets | $60.09M |
| Noncurrent Assets | $1.17M |
| Fixed Assets | $98.00K |
| Other Non-current Assets | $1.07M |
| Liabilities | $27.18M |
| Current Liabilities | $16.64M |
| Accounts Payable | $3.67M |
| Other Current Liabilities | $12.97M |
| Noncurrent Liabilities | $10.54M |
| Equity | $34.08M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $34.08M |
| Liabilities And Equity | $61.26M |
| Net Cash Flow From Operating Activities | -$52.77M |
| Net Cash Flow From Operating Activities, Continuing | -$52.77M |
| Net Cash Flow From Investing Activities | -$98.00K |
| Net Cash Flow From Investing Activities, Continuing | -$98.00K |
| Net Cash Flow From Financing Activities | -$1.74M |
| Net Cash Flow From Financing Activities, Continuing | -$1.17M |
| Exchange Gains/Losses | $1.53M |
| Net Cash Flow | -$53.63M |
| Net Cash Flow, Continuing | -$55.17M |
| Comprehensive Income/Loss | -$75.37M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$72.35M |
| Other Comprehensive Income/Loss | -$15.90M |